Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren.
- W. Riess, H. Stierlin, +9 authors J. Wagner
- Medicine
- Scandinavian journal of rheumatology. Supplement
- 1978
Diclofenac sodium, the active substance of Voltaren®, is totally absorbed following both oral and rectal administration and is excreted, mainly in metabolised form, partly in the urine and partly in… Expand
Perioperative medical management of patients with COPD
- M. Licker, A. Schweizer, C. Ellenberger, Jean-Marie Tschopp, J. Diaper, F. Clergue
- Medicine
- International journal of chronic obstructive…
- 1 December 2007
Chronic obstructive pulmonary disease (COPD) and heart diseases are considered independent risk factors for mortality and major cardiopulmonary complications after surgery. Coronary artery disease,… Expand
Stereological changes in the capillary network and nerve cells of the aging human brain
- W. Meier-Ruge, O. Hunziker, U. Schulz, H. Tobler, A. Schweizer
- Biology, Medicine
- Mechanisms of Ageing and Development
- 1 September 1980
Stereologic parameters of the capillaries and nerve cells of the brain cortex and putamen were investigated. Thirty-eight brains from subjects aged between 19 and 94 years were examined. All cases… Expand
A new metabolite of diclofenac sodium in human plasma.
- J. Faigle, I. Böttcher, +6 authors T. Winkler
- Chemistry, Medicine
- Xenobiotica; the fate of foreign compounds in…
- 1 October 1988
1. Among the phenolic metabolites of diclofenac in human plasma, an unknown compound (metabolite VI) was detected by h.p.l.c. and g.c. methods. This was also found in baboon plasma. 2. Metabolite VI… Expand
Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levels
- A. Schweizer, U. Feige, A. Fontana, K. Mueller, C. Dinarello
- Medicine
- Agents and Actions
- 1 September 1988
Interleukin-1 (IL-1) has been shown to induce inflammatory reactions in part through increased prostaglandin production. Prostaglandins of the E- and I-type sensitize nociceptors in peripheral… Expand
A sulphonamido-indanone derivative CGP 28237 (ZK 34228), a novel non-steroidal anti-inflammatory agent without gastro-intestinal ulcerogenicity in rats.
- I. Böttcher, A. Schweizer, M. Glatt, H. Werner
- Medicine
- Drugs under experimental and clinical research
- 1987
CGP 28237 (5-methylsulphonylamino-6-phenoxy-1-indanone) belongs to a series of structurally novel indanones. The compound is a weak acid (pK = 6.98), but it does not contain a carboxylic group. CGP… Expand
Architecture of cerebral capillaries in aged human subjects with hypertension.
- O. Hunziker, S. Al, U. Schulz, A. Schweizer
- Medicine
- Advances in neurology
- 1978
Postmortem changes in stereological parameters of cerebral capillaries.
- O. Hunziker, A. Schweizer
- Chemistry, Medicine
- Beitrage zur Pathologie
- 1977
The present study investigated the influence of different postmortem times on stereological parameters of capillaries in the cerebral cortex. For the human investigation different brain regions of… Expand
Pharmacological properties of five diclofenac metabolites identified in human plasma
- I. Wiesenberg-Boettcher, J. Pfeilschifter, A. Schweizer, A. Sallmann, P. Wenk
- Chemistry, Medicine
- Agents and Actions
- 1 September 1991
Five metabolites of diclofenac sodium (Voltarol®) have been identified in human plasma. All five metabolites were more than 50 times less potent than diclofenac in inhibiting PGE2 production in… Expand
Determination of total monohydroxylated metabolites of diclofenac in urine by electron-capture gas-liquid chromatography.
- A. Schweizer, J. V. Willis, D. Jack, M. Kendall
- Chemistry, Medicine
- Journal of chromatography
- 25 July 1980